265 related articles for article (PubMed ID: 30396283)
21. Nucleolin on the cell surface as a new molecular target for gastric cancer treatment.
Watanabe T; Hirano K; Takahashi A; Yamaguchi K; Beppu M; Fujiki H; Suganuma M
Biol Pharm Bull; 2010; 33(5):796-803. PubMed ID: 20460757
[TBL] [Abstract][Full Text] [Related]
22. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
Mosafer J; Mokhtarzadeh A
Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
[TBL] [Abstract][Full Text] [Related]
23. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
[TBL] [Abstract][Full Text] [Related]
24. Multifunctional AS1411-functionalized fluorescent gold nanoparticles for targeted cancer cell imaging and efficient photodynamic therapy.
Ai J; Xu Y; Lou B; Li D; Wang E
Talanta; 2014 Jan; 118():54-60. PubMed ID: 24274270
[TBL] [Abstract][Full Text] [Related]
25. Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo.
Alibolandi M; Taghdisi SM; Ramezani P; Hosseini Shamili F; Farzad SA; Abnous K; Ramezani M
Int J Pharm; 2017 Mar; 519(1-2):352-364. PubMed ID: 28126548
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy and cardioprotection of nucleolin-targeted doxorubicin-loaded ultrasound nanobubbles in treating triple-negative breast cancer.
Fang K; Wang L; Huang H; Dong S; Guo Y
Nanotechnology; 2021 Mar; 32(24):. PubMed ID: 33690196
[TBL] [Abstract][Full Text] [Related]
27. Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas.
Li L; Hou J; Liu X; Guo Y; Wu Y; Zhang L; Yang Z
Biomaterials; 2014 Apr; 35(12):3840-50. PubMed ID: 24486214
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of nucleolin as a COUP-TFII coactivator of retinoic acid receptor β transcription in breast cancer cells.
Litchfield LM; Riggs KA; Hockenberry AM; Oliver LD; Barnhart KG; Cai J; Pierce WM; Ivanova MM; Bates PJ; Appana SN; Datta S; Kulesza P; McBryan J; Young LS; Klinge CM
PLoS One; 2012; 7(5):e38278. PubMed ID: 22693611
[TBL] [Abstract][Full Text] [Related]
29. Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest.
Xu Z; Joshi N; Agarwal A; Dahiya S; Bittner P; Smith E; Taylor S; Piwnica-Worms D; Weber J; Leonard JR
J Neurooncol; 2012 May; 108(1):59-67. PubMed ID: 22382782
[TBL] [Abstract][Full Text] [Related]
30. A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis.
Shen N; Yan F; Pang J; Wu LC; Al-Kali A; Litzow MR; Liu S
Oncotarget; 2014 Jul; 5(14):5494-509. PubMed ID: 25015109
[TBL] [Abstract][Full Text] [Related]
31. CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer.
Yan Y; Narayan A; Cho S; Cheng Z; Liu JO; Zhu H; Wang G; Wharram B; Lisok A; Brummet M; Saeki H; Huang T; Gabrielson K; Gabrielson E; Cope L; Kanaan YM; Afsari A; Naab T; Yfantis HG; Ambs S; Pomper MG; Sukumar S; Merino VF
Oncogene; 2021 Sep; 40(38):5752-5763. PubMed ID: 34341513
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411.
Holmboe S; Hansen PL; Thisgaard H; Block I; Müller C; Langkjær N; Høilund-Carlsen PF; Olsen BB; Mollenhauer J
PLoS One; 2017; 12(5):e0178286. PubMed ID: 28542563
[TBL] [Abstract][Full Text] [Related]
33. Nucleolin inhibitor GroA triggers reduction in epidermal growth factor receptor activation: Pharmacological implication for glial scarring after spinal cord injury.
Goldshmit Y; Schokoroy Trangle S; Afergan F; Iram T; Pinkas-Kramarski R
J Neurochem; 2016 Sep; 138(6):845-58. PubMed ID: 27399849
[TBL] [Abstract][Full Text] [Related]
34. Topical application of a G-Quartet aptamer targeting nucleolin attenuates choroidal neovascularization in a model of age-related macular degeneration.
Leaderer D; Cashman SM; Kumar-Singh R
Exp Eye Res; 2015 Nov; 140():171-178. PubMed ID: 26368850
[TBL] [Abstract][Full Text] [Related]
35. Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell.
Lohlamoh W; Soontornworajit B; Rotkrua P
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2209-219. PubMed ID: 34319045
[TBL] [Abstract][Full Text] [Related]
36. Nucleolin targeting AS1411 modified protein nanoparticle for antitumor drugs delivery.
Wu J; Song C; Jiang C; Shen X; Qiao Q; Hu Y
Mol Pharm; 2013 Oct; 10(10):3555-63. PubMed ID: 23679916
[TBL] [Abstract][Full Text] [Related]
37. Aptamer-integrated α-Gal liposomes as bispecific agents to trigger immune response for killing tumor cells.
Hong S; Ding P; Luo Y; Gao T; Zhang Y; Pei R
J Biomed Mater Res A; 2019 Jun; 107(6):1176-1183. PubMed ID: 30650243
[TBL] [Abstract][Full Text] [Related]
38. A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy.
Trinh TL; Zhu G; Xiao X; Puszyk W; Sefah K; Wu Q; Tan W; Liu C
PLoS One; 2015; 10(11):e0136673. PubMed ID: 26523833
[TBL] [Abstract][Full Text] [Related]
39. Direct investigations of interactions between nucleolins and aptamers on pancreatic cancer and normal cells by atomic force microscopy.
Li X; Chen L; Kong S; Zhong H; Jiang F; Zhao W
Ultramicroscopy; 2024 Sep; 263():113986. PubMed ID: 38762964
[TBL] [Abstract][Full Text] [Related]
40. Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer.
Wolfson E; Solomon S; Schmukler E; Goldshmit Y; Pinkas-Kramarski R
Cell Death Dis; 2018 Jan; 9(2):47. PubMed ID: 29352243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
